Evidence map›Paper›PMID 41535935›Full record

ArticlePopulation health metrics2026

Socio-demographic, behavioral, and biological risk factors of hypertension in Kazakhstan: results of a national study.

Yevgeniy Zhukov, Kuanysh Nikatov, Ermek Dyussembekov, Rauan Kastey, Niyazbek Yerniyazov, Mukhtar Korabayev, Darina Menlayakova, Talgat Muminov, Shynar Tanabayeva, Ildar Fakhradiyev and 1 more

Abstract read
In one paragraph

Article in Population health metrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yevgeniy ZhukovS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.
Kuanysh NikatovS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.
Ermek DyussembekovS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.
Rauan KasteyCity clinical Hospital No7, Almaty, Kazakhstan.
Niyazbek YerniyazovMultidisciplinary hospital named after prof. Kh.Zh.Makazhanov, Karagandy, Kazakhstan.
Mukhtar KorabayevMunicipal State Enterprise on the Right of Economic Management "East Kazakhstan region Specialized Medical Center" of Health Care Administration of East Kazakhstan region, Kazakhstan region, Ust-Kamenogorsk, Kazakhstan.
Darina MenlayakovaS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.
Talgat MuminovS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.
Shynar TanabayevaS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.
Ildar FakhradiyevS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan. fakhradiyev.i@kaznmu.kz.
Marat ShoranovS.D.Asfendiyarov Kazakh National Medical University, 94, Tole-bi str., Almaty, 050020, Republic of Kazakhstan.

Funding

Ministry of Healthcare of the Republic of Kazakhstan BR27304987
6 · The paper itself

Abstract

backgroundArterial hypertension (AH) is a major contributor to cardiovascular morbidity and mortality worldwide. This study aimed to identify sociodemographic and biological factors associated with hypertension in a nationally representative adult sample in Kazakhstan.

methodsA cross-sectional WHO STEPS survey (October 2021-May 2022) included 6,720 adults aged 18-69 years from all regions of Kazakhstan. Sociodemographic, behavioral, physical and biochemical data were collected, hypertension was defined by ESC/ESH criteria.

resultsCrude AH prevalence was 16.0% (95% CI 15.1-16.8) and increased sharply with age from 3.0% at 18-24 years to 46.7% at ≥ 65 years (p < 0.001). Men had higher systolic (SBP) and diastolic blood pressure (DBP) than women (126/82 vs. 119/79 mmHg, p < 0.001) and a less favorable BP profile. Urban residents were younger and more likely to report smoking and alcohol use than rural residents (21.4% vs. 14.8% and 6.5% vs. 3.2%, p < 0.001), whereas rural participants had higher BMI, SBP, DBP, total cholesterol and HbA1c (p < 0.05). Hypertension prevalence showed marked regional heterogeneity, from 9.5% in Kyzylorda and 9.6% in Astana to 25.3% in Akmola and 23.7% in North Kazakhstan. In adjusted models, hypertension was independently associated with older age (OR 1.894, 95% CI 1.780-2.014, p < 0.001), higher BMI (OR 1.597, 95% CI 1.484-1.719, p < 0.001), higher total cholesterol (OR 1.171, 95% CI 1.098-1.249, p < 0.001) and urban residence (OR 1.304, 95% CI 1.121-1.517, p = 0.001), while female sex was protective (OR 0.596, 95% CI 0.511-0.696, p < 0.001). Smoking, HbA1c, education and ethnicity were not significant after adjustment, and alcohol intake showed a statistically detectable but clinically minimal association (OR 0.997, 95% CI 0.995-0.999).

conclusionIn 2021-2022, hypertension affected roughly one in six adults in Kazakhstan and rose steeply with age. Modifiable metabolic factors, particularly excess body weight and elevated cholesterol, were the main drivers of risk, while an independent urban effect and pronounced north-south regional differences highlight the need for targeted weight and lipid management and intensified long-term risk control, especially in cities and high-prevalence northern regions.

Indexed as

HypertensionAdolescentAdultAgedAlcohol DrinkingBlood PressureCross-Sectional StudiesFemaleHumansKazakhstanMaleMiddle AgedPrevalenceRisk FactorsRural PopulationSmokingHypertensionKazakhstanModifiableNon-modifiableRisk factors

Identifiers

PMID41535935
PMCPMC12888478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.